Compare AGRZ & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRZ | YI |
|---|---|---|
| Founded | 2020 | 2010 |
| Country | Malaysia | China |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Staples | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 49.0M |
| IPO Year | 2025 | N/A |
| Metric | AGRZ | YI |
|---|---|---|
| Price | $0.41 | $8.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 579.6K | 59.6K |
| Earning Date | 05-22-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2038.10 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | $14,879,848.00 | ★ $1,908,028,152.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.19 | ★ N/A |
| Revenue Growth | ★ 200.67 | N/A |
| 52 Week Low | $0.33 | $2.48 |
| 52 Week High | $7.20 | $11.35 |
| Indicator | AGRZ | YI |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 72.48 |
| Support Level | $0.40 | $7.01 |
| Resistance Level | $0.44 | $8.06 |
| Average True Range (ATR) | 0.08 | 1.06 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 28.78 | 49.34 |
Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.